Eli Lilly CEO David Ricks joins ‘Squawk Box’ to discuss the company’s quarterly earnings results, which reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion, demand outlook for Zepbound and Mounjaro, state of the weight loss drug competition, and more...Eli Lilly CEO on compounded versions of weight loss drugs 5430de1bf